LEUKOCYTE ADHESION MOLECULES AND MYOCARDIAL-ISCHEMIA

被引:34
作者
SMITH, CW [1 ]
ANDERSON, DC [1 ]
TAYLOR, AA [1 ]
ROSSEN, RD [1 ]
ENTMAN, ML [1 ]
机构
[1] BAYLOR UNIV, METHODIST HOSP, DEPT MED, CARDIOVASC SCI SECT, HOUSTON, TX 77054 USA
关键词
D O I
10.1016/1050-1738(91)90023-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Current evidence strongly indicates that neutrophils contribute to the injury seen after ischemia and reperfusion of various tissues. Potentially important therapeutic targets are the specific adhesion mechanisms supporting neutrophil extravasation and secretory activity. Several such mechanisms have been characterized recently at a molecular level in vitro, and warrant investigation in relevant models of human disease.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 37 条
[1]  
ANDERSON DC, 1986, J IMMUNOL, V137, P15
[2]  
ANDERSON DC, 1989, METABOLIC BASIS INHE, P2751
[3]   ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1 - AN INDUCIBLE RECEPTOR FOR NEUTROPHILS RELATED TO COMPLEMENT REGULATORY PROTEINS AND LECTINS [J].
BEVILACQUA, MP ;
STENGELIN, S ;
GIMBRONE, MA ;
SEED, B .
SCIENCE, 1989, 243 (4895) :1160-1165
[4]   MEMBRANE-PROTEINS INVOLVED IN PHAGOCYTE ADHERENCE TO ENDOTHELIUM [J].
CARLOS, TM ;
HARLAN, JM .
IMMUNOLOGICAL REVIEWS, 1990, 114 :5-28
[5]   NEUTROPHIL ACTIVATING FACTOR (NAF) INDUCES POLYMORPHONUCLEAR LEUKOCYTE ADHERENCE TO ENDOTHELIAL-CELLS AND TO SUBENDOTHELIAL MATRIX PROTEINS [J].
CARVETH, HJ ;
BOHNSACK, JF ;
MCINTYRE, TM ;
BAGGIOLINI, M ;
PRESCOTT, SM ;
ZIMMERMAN, GA .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 162 (01) :387-393
[6]  
CHARO IF, 1985, BLOOD, V65, P473
[7]   ICAM-1 (CD54) - A COUNTER-RECEPTOR FOR MAC-1 (CD11B CD18) [J].
DIAMOND, MS ;
STAUNTON, DE ;
DEFOUGEROLLES, AR ;
STACKER, SA ;
GARCIAAGUILAR, J ;
HIBBS, ML ;
SPRINGER, TA .
JOURNAL OF CELL BIOLOGY, 1990, 111 (06) :3129-3139
[8]   CANINE NEUTROPHIL ACTIVATION BY CARDIAC LYMPH OBTAINED DURING REPERFUSION OF ISCHEMIC MYOCARDIUM [J].
DREYER, WJ ;
SMITH, CW ;
MICHAEL, LH ;
ROSSEN, RD ;
HUGHES, BJ ;
ENTMAN, ML ;
ANDERSON, DC .
CIRCULATION RESEARCH, 1989, 65 (06) :1751-1762
[9]  
DREYER WJ, 1990, FASEB J, V4, pA893
[10]  
DUSTIN ML, 1986, J IMMUNOL, V137, P245